Alnylam Pharmaceuticals, Inc. v. Moderna, Inc. et al

Track this case

Case overview

Case Number:

1:22-cv-00925

Court:

Delaware

Nature of Suit:

Patent

Judge:

Colm F. Connolly

Firms

Companies

Sectors & Industries:

  1. August 25, 2023

    Alnylam, Moderna Agree To COVID Vax Patent Judgment

    Alnylam Pharmaceuticals Inc. and Moderna Inc. on Friday agreed to a final judgment of noninfringement in Alnylam's lawsuit alleging Moderna used patented biotechnology for its Spikevax coronavirus vaccine, following a Delaware federal judge's claim construction ruling, which Alnylam has vowed to appeal.

  2. May 12, 2023

    Moderna Fires Back At Rival's 'Baseless' Vaccine Patent Row

    Drugmaker Moderna has fired back at patent litigation lodged against it by a competitor last year over purportedly poached biotechnology in its coronavirus vaccine known as Spikevax, arguing that the asserted inventions are invalid and the infringement claims can't hold up in light of safe harbor protections.

  3. July 12, 2022

    Pfizer, Moderna Face New IP Litigation Over COVID Vaccines

    Pfizer and Moderna on Tuesday were targeted in another round of patent suits by rival Alnylam Pharmaceuticals over their COVID-19 vaccines, months after Alnylam claimed the vaccines ripped off a different aspect of its "breakthrough" biotechnology in related litigation.